On June 20 in Astana, representatives of the national company Kazakh Invest met with Vikram Vuppala, CEO of the Indian company NephroPlus to discuss the company’s plans for developing the dialysis market in Kazakhstan, Kazakh Invest reported.
Vikram Vuppala told the Kazakh representatives that NephroPlus considers Kazakhstan as a new market for investment in the framework of expanding its presence in Central Asia. The company’s initiative provides for opening new dialysis centers, partnership with local medical institutions, professional development of medical personnel, and the introduction of advanced dialysis technologies.
“We are confident that cooperation with international companies such as NephroPlus will help significantly improve the quality of medical services in the country. Kazakhstan is ready to provide all the necessary conditions for the successful implementation of this project,” Kazakh Invest’s representative Dinara Isabekova said.
The parties agreed to cooperate in the implementation of future projects in this industry.
NephroPlus is Asia’s largest network of dialysis centers, with more than 250 facilities in various Asian countries. The company provides high-quality dialysis services and offers a comprehensive approach to treating patients with chronic renal failure.
